* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Steel Factor Induces Serine Phosphorylation of
Extracellular matrix wikipedia , lookup
Cytokinesis wikipedia , lookup
Cell growth wikipedia , lookup
Tissue engineering wikipedia , lookup
Cell culture wikipedia , lookup
Cell encapsulation wikipedia , lookup
Organ-on-a-chip wikipedia , lookup
Cellular differentiation wikipedia , lookup
Tyrosine kinase wikipedia , lookup
List of types of proteins wikipedia , lookup
Signal transduction wikipedia , lookup
Paracrine signalling wikipedia , lookup
From www.bloodjournal.org by guest on August 3, 2017. For personal use only. Steel Factor Induces Serine Phosphorylation of Stat3 in Human Growth Factor-Dependent Myeloid Cell Lines By Akihiko Gotoh, Hiroyuki Takahira, Charlie Mantel, Sara Litz-Jackson, H. Scott Boswell, and Hal E. Broxmeyer Steel factor (SLF) acts synergistically with various hematopoietic growth factors that use the Jak-Stat pathways in vivo and in vitro, although the contribution by SLF to this pathway is unknown. We show here that SLF induces timeand dose-dependentphosphorylationof Stat3 in the human growth factor-dependent cell lines M07e and TF-1. This phosphorylation occurs exclusively on serine residues. Simultaneous stimulation with SLF plus other cytokines that induce tyrosine phosphorylation of Stat3, such as interleukin-9 (IL-9) in M07e cells or IL-6 in TF-1 cells, resulted in tyrosine phosphorylationand enhancedserine phosphorylation of Stat3. Serine phosphorylationalone did not promote nuclear translocation or DNA binding activity to the sis-inducible element of Stat3. However, costimulation with SLF plus IL-9 in M07e cells resulted in the nuclear translocation of serine-hyperphosphorylatedStat3. Serine phosphorylation of Stat3 was also observed by the stimulation of cells with granulocyte-macrophagecolony-stimulatingfactor and IL-3, which do not induce tyrosine phosphorylationof Stat3. These results suggest that SLF might modulate the JakStat3 pathway by serine phosphorylationand that the JakStat pathway may be differentially regulated by the combinational stimulation of two or more cytokines. 0 1996 by The American Society of Hematology. S proteins on a tyrosine immediately distal to the SH2 domain induces their homo- or hetero-dimerization through phosphotyrosine-SH2 interactions. As a consequence, they translocate to the nucleus, bind to specific promoter elements, and induce gene expression.' Although SLF has been found to act synergistically with various cytokines that use the Jak-Stat pathway, ie, granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3),I0 erythropoietin (EPO)," IL-9,'* and thrombopoietin (TPO),l3 the contribution by SLF to this pathway has not been described. In the present study, we show that SLF induces phosphorylation of Stat3 on serine but not on tyrosine residues in human factor-dependent myeloid cell lines. Serine phosphorylation of Stat3 alone does not promote nuclear translocation. However, costimulation by SLF with other cytokines that induce tyrosine phosphorylation of Stat3 resulted in translocation of serine-hyperphosphorylated Stat3 to the nucleus. TEEL FACTOR (SLF) is a potent costimulating cytokine that acts synergistically with a number of cytokines to stimulate growth of hematopoietic progenitor cells in vitro and blood cell production in vivo.' c-kit, the receptor for SLF, is a receptor-type protein tyrosine kinase (PTK) that is a member of the platelet-derived growth factor receptor family. Binding of SLF to the c-kit-encoded surface protein induces dimerization, followed by transphosphorylation and subsequent PTK activation.' The resulting tyrosine-phosphorylated c-kit receptor binds SH2-containing proteins such as phospholipase C-y (PLC-y), phosphatidylinositol 3-kinase, Syp, and HCP, which are in turn phosphorylated by the c-kif PTK.'.' The receptors for other cytokines and interferons of the cytokine superfamily are composed of one to three polypeptides and are constitutively associated with members of the Janus kinase (Jak) family of intracellular PTKs. Ligandbinding induces receptor oligomerization with concomitant Jak activation.6 The PTK substrates that are most directly implicated in signal transduction of the cytokine superfamily are the Stat (the signal transducers and activators of transcription) proteins. To date, six Stats have been cloned and characterized. These Stats possess an SH2 domain through which they bind specific phosphotyrosine sites on the activated receptor.' Each subfamily of cytokine receptors regulates a unique set of Stat proteins in a fashion that is determined by the SH2-binding specificity of the receptor phosphorylation sites.' Subsequent phosphorylation of Stat From the Departments of Medicine and Microbiology/lmmunology and the Walther Oncology Center, Indiana University School of Medicine, Indianapolis, IN. Submitted November 29, 199.5; accepted March 7, 1996. Supported by US Public Health Service Grants No. ROI HLS6416, R37 CA 36464, ROI HL 54037, and ROI HL 49202 and by a project in Grant No. POI HL 53586 from the National Cancer institute and the National Institutes of Health to H.E.B. Address reprint requests to Hal E. Broxmeyer, PhD, Walther Oncology Center, Indiana University School of Medicine, 975 W Walnut St, Indianapolis, IN 46202-5121. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section 1734 solely to indicate this fact. 0 1996 by The American Society of Hematology. 0006-4971/96/8801-oO30$3.00/0 138 MATERIALS AND METHODS Cells, cell culture, and cell proliferation assay. Human growth factor-dependent myeloid cell lines, M07e and TF- I , were cultured in RPMI 1640 supplemented with 20% fetal bovine serum (FBS) and 100 U/mL GM-CSF. These cell lines have been described elseBefore cytokine stimulation. these cells were washed twice, resuspended in RPMI 1640 supplemented with 0.5% bovine serum albumin (BSA), and then incubated for 18 hours without growth factors (factor starvation). ['Hlthymidine uptake was used to measure cell proliferation by incubation of triplicate aliquots of cells cultured in flat-bottom microtiter plates (1 X lo4 cellsll50 pL) with or without cytokines for 72 hours at 37°C. Cells were labeled with ['Hlthymidine (Amersham, Arlington Heights, IL) at 0.5 pCi/ well for the last 4 hours. Cytokines, antibodies, and reagents. Recombinant human (rhu) SLF, rhuIL-3, and rhuGM-CSF were kindly provided by Dr D.E. Williams (Immunex Co, Seattle, WA). rhuIL-6 and rhuIL-9 were obtained from R & D Systems (Minneapolis, MN). Anti-Stat2, Stat3, Stad, and Stat6 monoclonal antibodies (MoAbs), anti-ISGF3 polyclonal Ab, and anti-phosphotyrosine MoAb (PY20) were purchased from Transduction Laboratories (Lexington, KY). Anti-Stat3 and Stat4 polyclonal Abs and synthetic double-strand oligonucleotide corresponding to a binding site for sis-inducible factor (sis-inducible element [SIE]) and its mutant in the DNA binding region were from Santa Cmz Biotechnology Inc (Santa Cruz, CA). Agaroseconjugated antiphosphotyrosine (4G10) was obtained from Upstate Biotechnology, Inc (Lake Placid, NY). Horseradish peroxidase (HRP)-conjugated antimouse and antirabbit Ig and ['ZP]~rthoph~sphate were purchased from Amersham. Blood, VOI 88. NO 1 (July 1). 1996 pp 138-145 From www.bloodjournal.org by guest on August 3, 2017. For personal use only. 139 SERINE PHOSPHORYLATION OF Stat3 BY SLF In vivo labeling with "P. After factor starvation, cells were washed three times with Minimum Essential Medium without sodium phosphate (Sigma, St Louis, MO) and incubated for 45 minutes in the same medium supplemented with 10% dialyzed FBS at a cell density of 107/mL. [3ZP]orthophosphate(100 pCi/mL) was added and cells were further incubated for 3 hours. After stimulation with various cytokines, cells were washed with ice-cold phosphate-buffered saline and then lysed as described below. Cell lysis and nuclear extract preparation. Cells were lysed in lysis buffer as described previously." After 20 minutes on ice, insoluble fractions were removed by centrifugation at 14,000g for 20 minutes (whole cell lysate). Nuclear extract was prepared as described previously." Cells were washed with ice-cold buffer A (10 mmol/L HEPES, pH 7.9, 10 mmol/L KCl, 1.5 mmol/L MgCI2, 0.5 mmol/L dithiothreitol [DlT], 0.5 mmom phenylmethylsulfonyl fluoride [PMSF]) and were resuspended in buffer A containing 0.1 % Nonidet P-40 and incubated for 5 minutes on ice. The nuclear pellet was pelleted by centrifugation. The supematant was centrifuged for 20 minutes at 14,OOOg and the resulting supernatant was saved as cytoplasmic extracts. The nuclear pellets were rinsed with buffer A and resuspended in buffer C (20 mmol/L HEPES, pH 7.9,420 mmoY L NaCl, 1.5 mmol/L MgC12, 0.2 mmoVL EDTA, 0.5 mmol/L DTT, 0.5 mmol/L PMSF, 25% glycerol). After gently rocking for 15 minutes at 4"C, insoluble nuclear material was removed by centrifugation at 14,OOOg for 15 minutes. The protein concentration of these cell extracts was measured with a Bio-Rad protein assay (Bio-Rad, Hercules, CA). Equal amounts of protein were loaded in each lane or were used for immunoprecipitation and gel-mobility shift assay. Immunoprecipitation and immunoblotting. Immunoprecipitation and immunoblotting were performed as described previously.I6 Briefly, for immunoprecipitation, cell extracts were mixed with 1 pg of anti-Stat3 polyclonal Ab at 4°C for 2 hours. Antigen-Ab complexes were collected with protein A sepharose beads (Pharmacia Biotech, Uppsala, Sweden). Immunoprecipitates were washed with lysis buffer five to seven times before analysis. Immunoprecipitates and cell extracts were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene difluoride (PVDF) membrane (Millipore Corp, Bedford, MA). Membranes were blocked in Tris-buffered saline containing 0.5% Tween 20 and 1% BSA for 1 hour at room temperature and incubated with appropriate primary Abs for 2 hours. Blots were visualized using HRP-conjugated secondary Abs and an enhancedchemiluminescent system (ECL; Amersham). To reprobe with another first Ab, membranes were incubated in stripping buffer (62.5 mmol/L Tris, pH 6.7, 100 mmol/L 2-mercaptoethanol, 2% SDS) for 30 minutes at 50°C, washed, and then used for further study. Phosphoamino acid analysis. ["PI-labeled anti-Stat3 immunoprecipitates were separated by 7.5% SDS-PAGE, transferred to PVDF membranes, and visualized by autoradiography. The region corresponding to phosphorylated Stat3 on the membrane was excised and hydrolyzed in 6 N HCl. Phosphoamino acid analysis was then performed on nitrocellulose thin-layer chromatography plates (Merk, Darmstadt, Germany) as described previously with 1 pg each of standard phosphoamino acids in pH 3.5 electrophoresis buffer.'* Electric gel mobility shift assay (EMSA). EMSA was performed as described previously." A double-strand synthetic SIE consensus oligonucleotide (5'-GTG CAT TTC CCG TAA ATC l T G TCT ACA-3')'' was 5' end-labeled with [y3'P]ATP (Amersham) by polynucleotide T4 kinase (Boehringer Mannheim, Indianapolis, IN). Nuclear extract (5 pg) was incubated with 3 pg of poly(d1-dC) (Pharmacia Biotech) for 15 minutes on ice before adding 10,000 cpm of radiolabeled probe in binding buffer (20 mmol/L HEPES, pH 7.9, 20 mmoVL KCl, 5 mmol/L MgCl', 5 mmol/L D l T , 10% glycerol). For supershift assay, nuclear extract was preincubated with antiStat3 Ab or preimmune rabbit serum for 1 hour on ice. Competitions were performed with either the unlabeled homologous probe or a oligonucleotide mutated in the DNA binding region (5'-GTG CAT CCA CCG TAA ATC l T G TCT ACA-3'). After binding reaction for 10 minutes at room temparature, DNA-protein complexes were separated by 5% naive polyacrylamide gel in 0 . 2 5 ~TBE buffer. RESULTS Tyrosine phosphorylation of Stat family proteins in factordependent cell lines. Tyrosine phosphorylation of Stat family proteins, presumably by Jak family tyrosine kinases, has been shown to be essential for their DNA binding and transcriptional activation.' We first examined the effect of various hematopoietic growth factors on tyrosine phosphorylation of Stat family proteins in human factor-dependent cell lines, M07e and TF-1. Factor-starved M07e cells were stimulated with 100 ng/mL SLF, 200 U/mL GM-CSF, 200 U/ mL IL-3, or 5 ng/mL IL-9 for 10 minutes at 37°C. Whole cell lysates of cytokine-stimulated cells were immunoprecipitated with agarose-conjugated antiphosphotyrosine MoAb and immunoprecipitates were separated by SDS-PAGE followed by immunoblotting with specific antibodies against Stat family proteins. As shown in Fig lA, in M07e cells, Stat5 was found to be tyrosine-phosphorylated in response to GM-CSF, IL-3, and IL-9. Stat3 was tyrosine-phosphorylated by IL-9 (Fig 1B). Tyrosine phosphorylation of Stat3 reached a plateau at 5 ng/mL of IL-9 (data not shown). No tyrosine phosphorylation of either Stat5 or Stat3 was detected after 100 ng/mL of SLF stimulation. Tyrosine phosphorylation of other Stat family proteins tested (ISGF3, Stat2, Stat4, and Stat6) was not detectable or was very weak after stimulation with IL-9, GM-CSF, IL-3, or SLF in these conditions (data not shown). In TF-1 cells, which respond to the proliferative stimulation effect of IL-3, IL-6, GM-CSF, and SLF, but not to IL9, tyrosine phosphorylation of Stat5 by IL-3 and GM-CSF (Fig 1C) and tyrosine phosphorylation of Stat3 by IL-6 (Fig 1D) was observed. Maximal tyrosine phosphorylation of Stat3 was obtained by 20 ng/mL of IL-6 (data not shown). Thus, SLF had no effect on the tyrosine phosphorylation of Stat family proteins in TF-1 cells (Fig 1C and D) or in M07e cells (Fig 1A and B). Regarding GM-CSF, IL-3, and IL-6, these results confirm reports by others,'0.11.2' while these data show that IL-9 uses both Stat3 and Stat5 as downstream signaling pathways, probably as a result of activation of Jak family tyrosine kinases (Jakl, Jak2, and Tyk2) in M07e cells. Slower mobility of Stat3 in SDS-PAGE by SLF is caused by hyperphosphorylation. Immunoblotting of whole cell lysates with anti-Stat5 MoAb showed mobility shift of Stat5 in response t o tyrosine phosphorylation in M07e cells (Fig 2A). SLF did not modify mobility of Stat5 in SDS-PAGE (Fig 2A). Although SLF also did not induce tyrosine phosphorylation of Stat3 (Fig IB), slightly slower mobility of Stat3 in SDS-PAGE was observed in M07e cells treated with SLF compared with control medium-treated cells (Fig 2B). It has been reported by others that IL-6 and epidermal growth factor (EGF) induce two tyrosine-phosphorylated forms of Stat3 and that the slower band is serine phosphorylated.22,23 Unlike the results found in those previous reports, Stat3 in cells treated with SLF did not form doublet bands, but rather formed one slower band (Fig 2B). To investigate From www.bloodjournal.org by guest on August 3, 2017. For personal use only. GOTOH ET 140 A IP: B a-pTLr C 0 - PTL~ 0 2,332 J S5mgeJ Z V ) C I - - kba 117-F-89 a IP Y O - 117- - --stas Blok a-Stat5 IP a-pW C 89 89 - - Blot: a-Stat3 IP a D 451sa2 - PTL~ 117. -stat5 cSM3 89. a-Stat5 Blot: if this slower mobility was caused by phosphorylation of Stat3 on amino acids other than tyrosine, M07e cells were labeled with ['2P]orthophosphate and then stimulated with various cytokines. As shown in Fig 3, immunoprecipitation with anti-Stat3 Ab of ["PI-labeled cell lysates showed that 117 - 89 - a-.rrrm--Y?n Blot +stat5 a - Stat 5 117 - 89 - Blot -!Bat3 a-Stat3 Fig 2. Mobility change of Stat5 and Stat3 after stimulation of M07e cells. Factor-starved M07e cells were stimulated with the indicated cytokines for 10 minutes at 37°C. Whole cell lysates were separated by 7.5% SDS-PAGE and immunoblotted with anti-Stat5 MoAb (A) and anti-Stat3 MoAb (B). Concentrations of cytokines were the same as in Fia 1. Similar results were obtained in five indeDendent experiments. I c - 3 ":!i f g 2 kDa 117 Blot: AL u - a,-, .1 Fig 1. Tyrosine phosphorylation of Stat5 and Stat3 in M07e and TF-1 cells. Factor-starved M07e (A and Bl and TF-1 I C and D) cells were stimulated with indicated cytokines for 10 minutes at 37°C. Cells were lysed in lysis buffer and immunoprecipitated with agarose-conjugated antiphosphotyrosine MoAb. Immunoprecipitates were separated by 7.546 SDS-PAGE and immunobloted with anti-Stat5 MoAb IA and C) and anti-Stat3 MoAb IB and D). The concentrations of cytokines used were as follows: 100 nglmL SLF, 200 UlmL GMCSF, 200 UlmL IL-3.20 nglmL IL6, and 5 ng/mL IL-9. These are representative results of three independent studies. SLF can induce time- and dose-dependent phosphorylation of Stat3. Effect of SLF alone and in combination on phosphorylation ofStat3. Proliferative effects of SLF and cytokines that induced tyrosine phosphorylation of Stat3 were examined by ['Hlthymidine uptake. It was confirmed that SLF and IL-9 in M07e cells (Fig 4A) and SLF and IL-6 in TF-I cells (Fig 4B) had significant proliferative effects at the concentrations used in this study. Moreover, simultaneous stimulation with SLF plus these cytokines induced synergistic proliferation (Fig 4). We next determined the nature of SLF-induced Stat3 phosphorylation in more detail. "P-labeled factor-starved M07e cells were stimulated with cytokines, and Stat3 immunoprecipitates were analyzed by immunoblotting and autoradiography. Medium-treated cells showed basal phosphorylation of Stat3 (Fig 5C, lane 2) as compared with immunoprecipitation with preimmune serum (Fig 5C, lane I). Simultaneous stimulation with SLF plus IL-9, which induced synergistic proliferation of M07e cells (Fig 4A), resulted in enhanced phosphorylation of Stat3 (Fig 5C, lane 5 ) . Enhancement of overall phosphorylation was 3.5-fold by SLF, 2.5-fold by IL-9, and 4.2-fold by SLF plus IL-9 compared with medium-treated cells. In SLF plus IL-9-treated cells, tyrosine-phosphorylated Stat3 appeared as a single slightly slower migrating band in SDS-PAGE (Fig 5B, lane 5), whereas that of IL-9-treated cells appeared as a doublet band (Fig 5B, lane 4). To define amino acid residues phosphorylated by the stimulation with SLF, phosphoamino acid analysis was used. Regions corresponding to the mobility of Stat3 of the membrane were cut and hydrolyzed at the same time. Afterwards, all of the hydrolyzed amino acids were loaded in each lane and were separated on the same TLC plate. Figure 5D shows that SLF induces phosphorylation of Stat3 exclusively on serine residues. IL-9 induces tyrosine From www.bloodjournal.org by guest on August 3, 2017. For personal use only. SERINE PHOSPHORYLATION OF Stat3 BY SLF 141 A kDa 117 89- kDa 117- Autoradlography -.0 *stst3 2 5 -7. 10 30 n , . --r"+*. Blot: 90 mln. .-CSm3 89--( Blot: 60 a-Stat3 - a Stat 3 Fig 3. Time- and dose-dependent phosphorylationof Stat3 by SLF. Factor-starved M07e cells were labeled with ["Plotthophosphate. Cells were stimulated with 100 ng/mL SLF for the indicated period of time (A) or stimulated with the indicated concentrationof SLF for 7 minutes (B) at 37°C and then lysed in lysis buffer. These whole cell lysates were immunoprecipitatedwith anti-Stat3 Ab. One half of each immunoprecipitate was separated by 7.5% SDS-PAGE and blots were visualized by autoradiography.The rest of immunoprecipitateswere separated by 7.5% SDS-PAGE and immunoblotted with anti-Stat3 MoAb (left panels). Relative phosphorylationof Stat3 was determined by the densitometric analysis with autoradiography and normalized by relative Stat3 amount in these immunoprecipitates (right panels). Similar results were obtained from t w o separate experiments. phosphorylation and, to a lesser extent than does SLF, serine phosphorylation (Fig 5D). Densitometric analysis showed that serine phosphorylation was approximately 3.5 times higher after stimulation with 100 ng/mL of SLF-treated than in nontreated cells. Notably, simultaneous stimulation with SLF plus IL-9 induced phosphorylation of Stat3 on both serine and tyrosine residues (Fig 5D). Serine phosphorylation of Stat3 by the stimulation with SLF plus IL-9 was approximately 1.7 times higher than that of IL-9 alone as determined by densitometric analysis. Phosphorylation of Stat3 was also detected after stimulation with GM-CSF and IL-3 (Fig 5C, lanes 6 and 7), which were confirmed not to induce tyrosine phosphorylation of Stat3 (Fig 5B, lanes 6 and 7). Using densitometric analysis, phosphorylation of Stat3 was 3.5-fold and 2.7-fold enhanced, respectively, in GM-CSF- and IL-3-treated cells compared with medium-treated cells. GM-CSF and IL-3, which induced tyrosine phosphorylation of Stat5 but not Stat3, induced serine phosphorylation of Stat3 (Fig 5D). To confirm that serine phosphorylation of Stat3 by SLF is induced not only in M07e cells but also in other myeloid cells, TF- 1 cells were labeled with [."PI-orthophosphate and stimulated with SLF, IL-6, SLF plus IL-6, and GM-CSF. Phosphorylation of Stat3 was also shown in TF-I cells by the stimulation with SLF and GM-CSF (Fig 6C, lanes 3 and 6) that did not induce tyrosine phosphorylation of Stat3 (Fig 6B, lanes 3 and 6). Simultaneous stimulation with IL-6 plus SLF that induced synergistic proliferation in TF-I cells (Fig 4B) resulted in enhanced overall phosphorylation (Fig 6C, lane 5) and serine phosphorylation (Fig 6D) of Stat3 compared with that with IL-6 alone (Fig 6C, lane 4 and Fig 6D). After stimulation of cells with SLF plus IL-6, tyrosinephosphorylated Stat3 migrated as a slower single band in SDS-PAGE (Fig 6B, lane 5) compared with cells stimulated with IL-6 alone (Fig 6B, lane 4). Also, stimulation with 100 nmol/L 12-0-tetradecanoyl phorbol- 13-acetate(TPA) for 10 minutes induced serine phosphorylation but not tyrosine phosphorylation of Stat3 both in M07e and TF-I cells (data not shown). Translocation of hyper-phosphoylated Stat3 to the nucleus. For transcriptional activity of Stat3, translocation from the cytoplasm to the nucleus is a crucial event. In this context, we examined the localization of Stat3. Cytoplasmic and nuclear extracts were prepared from M07e cells stimulated with SLF andor IL-9. Immunoblotting of nuclear extracts with anti-Stat3 MoAb showed translocation of Stat3 to the nucleus in response to IL-9 and IL-9 plus SLF in M07e cells (Fig 7A). SLF alone had no effect on this translocation of Stat3, and GM-CSF did not induce translocation (Fig 7A). Stat3 was observed in the cytoplasm and was From www.bloodjournal.org by guest on August 3, 2017. For personal use only. GOTOH ET AL 142 [3H ] thymidine incorporation x 103cpm A none P M07e I SLF IL-9 translocated Stat3 showed that Stat3 in the nucleus was phosphorylated both on serine and tyrosine residues (data not shown), and the ratio of "P incorporated into serine/tyrosine was increased from 5.3 to 8.6 by simultaneous stimulation of cells with IL-9 plus SLF (Fig 7E). Activation of DNA binding activih containing Stat3 in response to IL-9 or simultaneous stimulation with IL-9 plus SLF. Stat3 is known to bind SIE DNA consensus site upon a~tivation.'.'~Therefore, SIE binding activity was assessed by EMSA with nuclear extracts of SLF and/or IL-9-treated M07e cells. As shown in Fig 8, IL-9 activated a specific DNA-binding protein (Fig 8, lane 3) whose binding could be competed with excess unlabeled probe itself but not by the unlabeled probe mutated in the DNA binding region (Fig 8, lanes 5 and 7). This DNA binding activity was not observed in nontreated cells or after SLF treatment alone (Fig x 103cpm B 5 10 15 20 none 1 2 3 mot SLF B 117 2 11-6 ea1 SLF+IL-6 2 3 117- 6 7 4 5 CSt.13 6 7 - n P3r Blot c k l h 5 -- k h - Fig 4. Synergistic proliferation of M07e and TF-1 cells by the stimulation with SLF plus cytokines that induce Stat3 tyrosine phosphorylation. Factor-starved M07e (A) or TF-1 (B) cells were plated at 1 x 10' per well in RPMl 1640 containing 596 FBS with indicated cytokines. The concentrations of cytokines used were as follows: 100 n g l mL SLF, 5 ng/mL IL-9, and 20 nglmL IL-6. Cells were labeled with I'Hlthymidine for the last 4 hours of 72 hours of culture and then the amount of incorporated ['Hlthymidine was calculated using a scintillation counter. Data are the mean of triplicate culture SD. P values were measured using the unpaired Student's t-test. " P < .0005 v control medium; * * P < .005 v control medium; # P < .0001 for greater than additive effects. 4 a-Slat3 p 891 2 3 4 5 6 7 Autoradlogmphy D P-p-Thr serine-phosphorylated after stimulation of cells with SLF (data not shown). These results suggest that serine phosphorylation occurs in the cytoplasm and phosphorylation on tyrosine but not on serine residues is crucial for nuclear translocation of Stat3. Although the protein amount and tyrosine phosphorylation state of nuclear Stat3 were almost equal between IL-9 stimulation and IL-9 plus SLF stimulation (Fig 7B and C), overall phosphorylation was enhanced approximately 1.6-fold by stimulation with IL-9 plus SLF (Fig 7D). Furthermore, nuclear Stat3 formed a doublet band in SDS-PAGE after stimulation of the cells with IL-9 alone, whereas Stat3 formed a single slower migrating band after stimulation with IL-9 plus SLF (Fig 7B and C). Phosphoamino acid analysis of nuclear- P - V None SLF IL9 SLF +IL9 IL3 GM Fig 5. Phosphorylation and phosphoamino acid analysis of Stat3 in M07e cells. Factor-starved M07e cells labeled with "P were stimulated with SLF I100 nglmL), IL-9 (5 nglmLI, SLF + IL-9, GM-CSF (200 UlmL), or IL-3 (200 UlmL) for 10 minutes at 37°C. Anti-Stat3 immunoprecipitates or an immunoprecipitate with preimmune rabbit serum as a mock control were separated by 7.5% SDS-PAGE and immunoblotted with anti-Stat3 MoAb (A) or with antiphosphotyrosine MoAb (B) and visualized by autoradiography IC). Lane 1, mock; lane 2, control medium; lane 3, SLF; lane 4, IL-9; lane 5, SLF + IL-9; lane 6, GM-CSF; lane 7, IL-3. The corresponding region of Stat3 in the membrane was excised and phosphoamino acid analysis was performed (D) as described in the Materials and Methods. These are representative results of three independent experiments. From www.bloodjournal.org by guest on August 3, 2017. For personal use only. 143 SERINE PHOSPHORYLATION OF Stat3 BY SLF myeloid cell lines. It has been reported by others that the PMSP sequence, conserved in the C-terminal region of Stat la, Stat3, and Stat4, is similar to the MAP kinase recognition consensus sites.'? We have previously reported that MAP kinase is activated after stimulation with SLF and GMCSF but not with IL-9.'"'' Moreover, it has recently been reported by others that dominant negative MAP kinase inhibits interferon-D-induced transcription in human fibroblasts." These lines of evidence suggest that MAP kinase might play a role in the serine phosphorylation of Stat3 by SLF. The serine-threonine kinase cascade activated by SLF and GM-CSF involves not only MAP kinase but also raf-l and other serine kinases that are downstream of MAP kinase and protein kinase C that might be activated as a result of PLC--y activation.'"*' In the future, it should be determined which serine kinase is responsible for serine phosphorylation - Blot: u aiai J kUa 11789 1 2 3 111- -- 80- . kDa - 4 5 6 a pTLr Blot: r . I - A 1 2 3 4 5 kDa 6 z": 2 2 2 2 5 Autoradlagraphy -.~ 117- 89- 4-stat3 - Blot: a Stat 3 P-* p-Thr P-TLr SLF None IL6 SLF GM +IL6 Fig 6. Phosphorylation and phosphoamino acid analysis of Stat3 in TF-1 cells. Factor-starved TF-1 cells labeled with 32Pwere stimulated with SLF (100 nglmLI, 11-6 (20 nglmLI, SLF + IL-6, and GM-CSF (200 UlmL) for 10 minutes at 37°C. Anti-Stat3 immunoprecipitates were separated by 7.5% SDS-PAGE and immunoblotted with antiStat3 MoAb (A) or with antiphosphotyrosine MoAb (B) and visualized by autoradiography (C). Lane 1, mock; lane 2, control medium; lane 3, SLF; lane 4, IL-6; lane 5, SLF IL-6; lane 6, GM-CSF. The corresponding region of Stat3 was excised and subjected t o phosphoamino acid analysis 1D). Similar results were obtained from three independent experiments. + D E - Autoradiography 11-9 8, lanes 1 and 2). Simultaneous stimulation of cells with IL9 and SLF induced an SIE binding activity that comigrated in EMSA with that induced by IL-9 alone (Fig 8, lanes 4 and 8). These DNA-protein complexes were shown to contain Stat3 by performing a supershift with an anti-Stat3 Ab that resulted in the retarded migration of the complexes (Fig 8, lanes 9 and IO). DISCUSSION The role of tyrosine phosphorylation for Stat family proteins are well delineated. We describe here for the first time that cytokines that do not induce tyrosine phosphorylation of Stat3, such as SLF, GM-CSF, and IL-3, can induce serine phosphorylation of Stat3 in human growth factor-dependent SLF+IL-B Fig 7. Phosphorylation of nuclear translocated Stat3 by the simultaneous stimulation with SLF and IL-9. Factor-starved M07e cells were labeled with "P and stimulated with SLF (100 ng/mL), IL-9 15 nglmL), SLF + IL-9, and GM-CSF (200 UlmLl for 10 minutes at 37°C. Nuclear extracts were prepared as described in the Materials and Methods and then separated by 7.5% SDS-PAGE followed by immunoblotting with anti-Stat3 MoAb (A). Anti-Stat3 immunoprecipitates of nuclear extracts stimulated with IL-9 alone or SLF + IL-9 were separated by 7.5% SDS-PAGE and immunoblotted with anti-Stat3 MoAb (B)or immunoblotted with antiphosphoryrosine MoAb (C) and visualized by autoradiography (D1. These results are representative of four independent experiments. The corresponding region of Stat3 was excised and subjected t o phosphoamino acid analysis, and then corresponding regions of tyrosine phosphorylation and serine phosphorylation were quantitated by densitometry. The ratio of 32Pincorporated serineltyrosine was calculated. Pvalue was measured using the unpaired Student's t-test. *P < .01 (El. From www.bloodjournal.org by guest on August 3, 2017. For personal use only. GOTOH ET AL 144 Antibody: = = 5 5 d W S l Competitor: SLF Treatment: IL-Q - + - + - + - + - + - + + + + + + + + + + + - - ss+ b freeprobe+ 1 2 3 4 5 6 7 8 9 1 0 1 1 1 2 Fig 8. EMSA analysis of SIE binding activity in M07e cells. Factorstarved M07e cells (1 x 1O8/samplel were stimulated with control medium (lane 11, SLF (100 nglmL, lane 21, IL-9 (5nglmL, lanes 3, 5, 7,9, and 111, and SLF + 11-9 (lanes 4,6,8, 10, and 121 for 10 minutes at 37°C. Nuclear extracts were prepared and EMSA was performed as described in the Materials and Methods using a double-strand syntheticoligonucleotidecorrespondingto SIE (5‘-GTG CAT TTC CCG TAA ATC l T G TCT ACA-3‘1. Competitions were performed with excess (100x1 unlabeled homologous oligonucleotide (lanes 5 and 6) or mutated oligonucleotide (5’-GTG CAT CCA CCG TAA ATC l T G TCT ACA-3’; lanes 7 and 8 ) . Supershifts were performed with anti-Stat3 Ab (lanes 9 and 101 or preimmune rabbit serum (lanes 11 and 12). The positions of the specific complex and the supershifted complex (SSI are indicated. Similar results were obtained in three independent experiments. of Stat3 for a further understanding of Stat-mediated signaling. However, the fact that TPA can induce serine phosphorylation of Stat3 (data not shown) suggests that, at least in part, activation of protein kinase C might be involved in this process. The biological significance of phosphorylation on serine residues of Stat family proteins remains to be defined. However, recent reports have begun to clarify the importance of serine phosphorylation of Stats. Serine phosphorylation is reported to be required to form complexes of DNA with Stat3 homo-dimers.22Our data showed that serine phosphorylation alone by SLF did not induce nuclear translocation or DNA binding activity of Stat3 (Figs 7A and 8). However, simultaneous stimulation of the cells with SLF plus other cytokines that induce tyrosine phosphorylation of Stat3 resulted in the translocation of the serine-hyperphosphorylatedStat3 to the nucleus (Fig 7). This suggest that SLF might modulate JakStat pathway. Because GM-CSF and IL-3 also induced serine but not tyrosine phosphorylation of Stat3 (Figs 5 and 6). Jak-Stat pathway could be modulated by the hematopoietic progenitor cells that express particular sets of the cytokine receptors in the presence of multiple cytokines. EMSA using an SIE oligonucleotide as probe showed that IL-9 and IL-9 plus SLF induced a DNA binding activity that containing Stat3 in M07e cells (Fig 8). Although these results did not clarify the role of serine hyperphosphorylation of Stat3, it is possible that transcriptional activity of serine-phosphorylated Stat3 is augmented without affecting its DNA binding or that IL-9 plus SLF can induce distinct DNA binding activity other than SIE. Mechanisms underlying the synergism of SLF and other cytokines remain largely unknown, although a number of possible candidate intracellular events have been implicated.?7’?clConsidering SLF synergy, our observation is potentially important. First, increased phosphorylation of Stat3 by SLF plus IL-9 in M07e cells (Fig SC, lane 5 ) and by SLF and 1L-6 in TF-I cells (Fig 6C. lane 5 ) corresponds to increased mitogenesis at the cellular level (Fig 4). Second, translocation of serine-hyperphosphorylated Stat3 to the nucleus can be achieved only by the simultaneous stimulation of SLF and other cytokines that use Stat3 but not by SLF alone (Fig 7). It is noteworthy that others have reported recently that maximal activation of transcription by Stat la and Stat3 requires both tyrosine and serine phosphorylation.” Thus, it is highly possible that concomitant stimulation with SLF and other cytokines that use Stat3 can induce a higher transcriptional activation status of Stat3 in hematopoietic progenitor cells. It has been reported by others that dominant negative StatS inhibits IL-3-dependent cell growth3”and that StatS antisense oligodeoxynucleotides inhibit proliferation followed by erythroid differentiation in Friend virus-transformed murine erythroleukemia cells.” Therefore, it is likely that the Jak-Stat3 pathway might also contribute to some proliferation process(es). In addition, in U937 monocytic cells, during differentiation induced by interferon-y, Stat1 is reported to be phosphorylated on serine residues but not on tyrosine residues.” This finding suggests that serine phosphorylation of Stats might play a role in the differentiation process in some cell types. The contribution of Jak-Stat pathways to the functional response of hematopoietic progenitor cells requires further investigation. However, taken together with these previous reports and our data presented here, serine phosphorylation of Stat3 by SLF and other cytokines, especially through simultaneous stimulation with hematopoietic growth factors that induce tyrosine phosphorylation of Stat3, might be involved in the regulation of proliferation and/or differentiation of myeloid stem and progenitor cells. ACKNOWLEDGMENT We thank Rebecca Miller for her assistance in preparation of this manuscript. REFERENCES I . Broxmeyer HE,Maze R, Miyazawa K,Carow C, Hendrie PC, Cooper S, Hangoc G, Vadhan-Raj S , Lu L The kit receptor and its ligand Steel factor as regulators of hemopoiesis. Cancer Cells 3:480, 1991 From www.bloodjournal.org by guest on August 3, 2017. For personal use only. SERINE PHOSPHORYLATION OF Stat3 BY SLF 2. Heldin CH: Dimerization of cell surface receptors in signaling transduction. Cell 80:213, 1995 3. Rottalpel R, Reedijk M, Williams DE, Lyman SD, Anderson DM, Pawson T, Bemstein A: The S t e e W transduction pathway: Kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the steel factor. Mol Cell Biol 11:3043, 1991 4. Tauchi T, Feng G-S, Marshall MS, Shen R, Mantel C, Pawson T, Broxmeyer HE: The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells. J Biol Chem 269:25206, 1994 5 . Yi T, Ihle JN: Association of hematopoietic cell phosphatase with c-kit after stimulation with c-kit ligand. Mol Cell Biol 13:3350, 1993 6. Ihle JN, Kerr IM: Jaks and Stats in signaling by cytokine receptor superfamily. Trends Genet 11:69, 1995 7. Hill CS, Treisman R: Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 80:199, 1995 8. Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell JE Jr, Yancopoulos GD: Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267:1349, 1995 9. Damell JE Jr, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415, 1994 10. Mui AL, Wakao H, O’Farrell AM, Harada N, Miyajima A: Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two Stat5 homologs. EMBO J 14:1166, 1995 11. Gouilleux F, Pallard C, Dusanter-Fourt I, Wakao H, Haldosen LA, Norstedt G, Levy D, Groner B: Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J 14:2005, 1995 12. Yin T, Yang L, Yang YC: Tyrosine phosphorylation and activation of JAK family tyrosine kinases by interleukin-9 in M07E cells. Blood 85:3101, 1995 13. Sattler M, Durstin MA, Frank DA, Okuda K, Kaushansky K, Salgia R, Griffin JD: The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. Exp Hematol 23:1040, 1995 14. Avanzi GC, Lista P, Giovinazzo B, Miniero R, Saglio G, Benetton G, Coda R, Cattoretti G, Pegoraro L: Selective growth response to IL-3 of a human leukemic cell line with megakaryoblastic features. Br J Haematol 69:359, 1988 15. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao Y-F, Miyazono K, Urabe A, Takaku F: Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 140:323, 1989 16. Gotoh A, Miyazawa K, Ohyashiki K, Tauchi T, Boswell HS, Broxmeyer HE, Toyama K: Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein. Exp Hematol 23:1153, 1995 17. Stewart MJ, Litz-Jackson S, Burgess GS, Williamson EA, Leibowitz DS, Boswell HS: Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells. Leukemia 9:1499, 1995 18. Miyazawa K, Hendrie PC, Mantel C, Wood K, Ashman LK, Broxmeyer HE: Comparative analysis of signaling pathways between mast cell growth factor (c-kit ligand) and granulocyte-macro- 145 phage colony stimulating factor in a human factor-dependent myeloid cell line involves phosphorylation of Raf- 1, GTPase-activating protein and mitogen-activated protein kinase. Exp Hematol 19:11 10, 1991 19. Yip-Schneider MT, Horie M, Broxmeyer HE: Transcriptional induction of pim-1 protein kinase gene expression by interferon y and posttranscriptional effects on costimulation with Steel factor. Blood 85:3494, 1995 20. Sadowski HB, Shuai K, Damell JE Jr, Gilman M Z : A common nuclear signal transduction pathway activated by growth factor cytokine receptors. Science 261 :1739, 1993 21. Akira S, Nishio Y. Inoue M, Wang X-J, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T Molecular cloning of APRF, a novel IFN-stimulating gene factor 3 p91-related transcription factor involved in the gpl30-mediated signaling pathway. Cell 77:63, 1994 22. Zhang X, Belnis J, Darnell JE Jr: Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267: 1990, 1995 23. Wen Z, Zhong Z, Darnell JE Jr: Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241, 1995 24. Tweardy DJ, Wright TM, Ziegler SF, Baumann H, Chakraborty A, White SM, Dyer KF, Rubin KA: Granulocyte colony-stimulating factor rapidly activates a distinct STAT-like protein in normal myeloid cells. Blood 864409, 1995 25. Miyazawa K, Hendrie PC, Kim Y-J, Mantel C, Yang Y-C, Kwon BS, Broxmeyer HE: Recombinant human interleukin-9 induces protein tyrosine phosphorylation and synergizes with Steel factor to stimulate proliferation of the human factor-dependent cell line, M07e. Blood 80:1685, 1992 26. David M, Petricon E 111, Benjamin C, Pine R, Weber MJ, Lamer AC: Requirement for MAP kinase (ERK2) activity in interferon a-and interferon P-stimulated gene expression through STAT proteins. Science 269:1721, 1995 27. Aronica SM, Mantel C, Gonin R, Marshall MS, Sanis A, Cooper S, Hague N, Zhang X-F, Broxmeyer HE: Interferon-inducible protein 10 and macrophage inflammatory protein-la inhibit growth factor stimulation of Raf-1 kinase activity and protein synthesis in a human growth factor-dependent hematopoietic cell line. J Biol Chem 270:21998, 1995 28. Horie M, Broxmeyer HE: Involvement of immediate-early gene expression in the synergistic effects of steel factor in combination with granulocyte-macrophage colony-stimulating factor or interleukin-3 on proliferation of a human factor-dependent cell line. J Biol Chem 268:968, 1993 29. Mantel C, Luo Z, Hendrie P, Broxmeyer HE: Steel factor and granulocyte-macrophage colony stimulating factor act together to enhance choline-lipid turnover during synergistically stimulated proliferation of the human factor dependent cell line, M07e. Biochem Biophys Res Commun 197:978, 1993 30. Mui A, Wakao H, Kitamura T, Miyajima A: Dominant negative Stat5 inhibits interleukin-3 (IL3) dependent proliferation. Blood 86:252a, 1995 (abstr, suppl 1 ) 31. Merchav S, Barber DL, D’Andrea AD: Stat5 antisense oligodeoxynucleotides enhances the differentiation of murine erythroleukemia cells. Blood 86:252a, 1995 (abstr, suppl 1) 32. Elilers A, Georgellis D, Klose B, Schindler C, Decker T: Differentiation-regulated serine phosphorylation of Stat 1 promotes GAF activation in macrophages. Mol Cell Biol 15:3579, 1995 From www.bloodjournal.org by guest on August 3, 2017. For personal use only. 1996 88: 138-145 Steel factor induces serine phosphorylation of Stat3 in human growth factor-dependent myeloid cell lines A Gotoh, H Takahira, C Mantel, S Litz-Jackson, HS Boswell and HE Broxmeyer Updated information and services can be found at: http://www.bloodjournal.org/content/88/1/138.full.html Articles on similar topics can be found in the following Blood collections Information about reproducing this article in parts or in its entirety may be found online at: http://www.bloodjournal.org/site/misc/rights.xhtml#repub_requests Information about ordering reprints may be found online at: http://www.bloodjournal.org/site/misc/rights.xhtml#reprints Information about subscriptions and ASH membership may be found online at: http://www.bloodjournal.org/site/subscriptions/index.xhtml Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published weekly by the American Society of Hematology, 2021 L St, NW, Suite 900, Washington DC 20036. Copyright 2011 by The American Society of Hematology; all rights reserved.